NO922004L - Oralt preparat for behandling av inflammatoriske tarmsykdommer - Google Patents

Oralt preparat for behandling av inflammatoriske tarmsykdommer

Info

Publication number
NO922004L
NO922004L NO92922004A NO922004A NO922004L NO 922004 L NO922004 L NO 922004L NO 92922004 A NO92922004 A NO 92922004A NO 922004 A NO922004 A NO 922004A NO 922004 L NO922004 L NO 922004L
Authority
NO
Norway
Prior art keywords
treatment
disorders
oral preparation
crohn
inflammatory
Prior art date
Application number
NO92922004A
Other languages
English (en)
Other versions
NO304010B1 (no
NO922004D0 (no
Inventor
Jan Ulmius
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377544&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO922004(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Draco Ab filed Critical Draco Ab
Publication of NO922004D0 publication Critical patent/NO922004D0/no
Publication of NO922004L publication Critical patent/NO922004L/no
Publication of NO304010B1 publication Critical patent/NO304010B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
NO922004A 1989-11-22 1992-05-21 FremgangsmÕte for fremstilling av en pelletformulering for bruk i behandlingen av inflammatoriske tarmsykdommer NO304010B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8903914A SE8903914D0 (sv) 1989-11-22 1989-11-22 Oral composition for the treatment of inflammatory bowel diseases
PCT/SE1990/000738 WO1991007172A1 (en) 1989-11-22 1990-11-15 Oral composition for the treatment of inflammatory bowel diseases

Publications (3)

Publication Number Publication Date
NO922004D0 NO922004D0 (no) 1992-05-21
NO922004L true NO922004L (no) 1992-05-21
NO304010B1 NO304010B1 (no) 1998-10-12

Family

ID=20377544

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922004A NO304010B1 (no) 1989-11-22 1992-05-21 FremgangsmÕte for fremstilling av en pelletformulering for bruk i behandlingen av inflammatoriske tarmsykdommer

Country Status (36)

Country Link
US (1) US6423340B1 (no)
EP (1) EP0502092B1 (no)
JP (1) JP3145111B2 (no)
KR (1) KR0179042B1 (no)
AT (1) ATE125445T1 (no)
AU (1) AU643021B2 (no)
CA (1) CA2071518C (no)
DE (1) DE69021214T2 (no)
DK (1) DK0502092T3 (no)
EG (1) EG19642A (no)
ES (1) ES2074698T3 (no)
FI (2) FI104949B (no)
GR (1) GR3017691T3 (no)
HK (1) HK51897A (no)
HR (1) HRP920632B1 (no)
HU (2) HUT60630A (no)
IE (1) IE74854B1 (no)
IL (1) IL96415A (no)
IS (1) IS1858B (no)
LT (1) LT3696B (no)
LV (1) LV10183B (no)
MY (1) MY104535A (no)
NO (1) NO304010B1 (no)
NZ (1) NZ235807A (no)
PL (1) PL166506B1 (no)
PT (1) PT95946A (no)
RU (1) RU2134104C1 (no)
SA (1) SA90110123B1 (no)
SE (1) SE8903914D0 (no)
SG (1) SG54210A1 (no)
SI (1) SI9012150A (no)
TW (1) TW250435B (no)
UA (1) UA37196C2 (no)
WO (1) WO1991007172A1 (no)
YU (1) YU48583B (no)
ZA (1) ZA908777B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316772A (en) * 1990-12-19 1994-05-31 Solvay & Cie, S.A. (Societe Anonyme) Bilayered oral pharmaceutical composition with pH dependent release
SK87295A3 (en) * 1993-01-08 1996-04-03 Astra Ab Novel colon or ileum-specific steroid derivatives
US5914132A (en) * 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE4332394A1 (de) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
KR20000053327A (ko) * 1996-11-15 2000-08-25 데이비드 엠 모이어 결장내 운반에 사용되는 약학적 제형
SE9604751D0 (sv) 1996-12-20 1996-12-20 Astra Ab New therapy
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US6239120B1 (en) 1998-03-17 2001-05-29 Pharmalink Ab Method and means for treating glomerulonephritis
GB9824604D0 (en) 1998-11-11 1999-01-06 Hewlett Healthcare Limited Treatment of allergic conditions
SE9902673D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
AU2002254205B2 (en) * 2001-03-15 2007-05-10 Enteron Pharmaceuticals, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
DE10250543A1 (de) * 2002-10-29 2004-05-19 Röhm GmbH & Co. KG Mehrschichtige Arzneiform
PT1572217E (pt) 2002-12-12 2008-11-28 Nycomed Gmbh Medicamento combinado de r,r-formoterol e ciclesonida
WO2004087109A1 (ja) * 2003-03-27 2004-10-14 Hisamitsu Pharmaceutical Co., Inc. 大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
US20060211668A1 (en) * 2003-09-15 2006-09-21 Altana Pharma Ag Use of ciclesonide for the treatment of inflammatory bowel diseases
PL1670482T5 (pl) 2003-09-16 2022-10-03 Covis Pharma Gmbh Zastosowanie cyklezonidu w leczeniu chorób układu oddechowego
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
US20070243184A1 (en) * 2005-11-08 2007-10-18 Steven Fischkoff Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
CA2684655A1 (en) * 2007-03-26 2008-10-02 Teikoku Seiyaku Co., Ltd. Oral pharmaceutical preparation for colon-specific delivery
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
EP2334178A4 (en) * 2008-10-03 2012-04-11 Falk Pharma Gmbh COMPOSITIONS AND METHODS OF TREATING THERAPEUTIC DISEASES WITH GRANULATED MESALAMINE
US8945616B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
US8945615B2 (en) * 2009-02-17 2015-02-03 Mylan Pharmaceuticals Inc. Controlled release budesonide minitablets
CA2826662A1 (en) * 2011-02-04 2012-08-09 Optimer Pharmaceuticals, Inc. Treatment of bacterial infections
MD480Z5 (ro) * 2011-07-07 2012-09-30 Эльвира АНДОН Metodă de tratament al colitei ulceroase nespecifice acute
HUE036187T2 (hu) 2012-04-30 2018-06-28 Tillotts Pharma Ag Késleltetett leadású gyógyszerkészítmény
UA117260C2 (uk) 2013-10-29 2018-07-10 Тиллоттс Фарма АГ Лікарський препарат з відстроченим вивільненням
WO2017042835A1 (en) * 2015-09-11 2017-03-16 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical dosage forms of budesonide
CN105663091A (zh) * 2016-01-28 2016-06-15 上海信谊百路达药业有限公司 一种布地奈德肠溶缓释胶囊及其制备方法
ES2874546T3 (es) * 2016-02-09 2021-11-05 Albireo Ab Formulación oral de colestiramina y uso de la misma
EP3413877B1 (en) * 2016-02-09 2021-04-07 Albireo AB Oral cholestyramine formulation and use thereof
EP3613414A1 (de) 2018-08-24 2020-02-26 Dr. Falk Pharma Gmbh Pellets mit mehrschichtiger struktur zur verzögerten freisetzung des wirkstoffs im distalen kolon
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996356A (en) 1969-07-02 1976-12-07 Hoffmann-La Roche Inc. Composition containing 5-sulfanilamido-3,4-dimethylisoxazole and a trimethoxybenzyl pyrimidine
SE378109B (no) 1972-05-19 1975-08-18 Bofors Ab
SE7813246L (sv) 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
FR2471186A1 (fr) 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
SE8003805L (sv) 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
SE8008524L (sv) 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
SE8306370D0 (sv) 1983-11-18 1983-11-18 Draco Ab Novel androstane-17beta-carboxylic acid esters, a process and intermediates for their preparation, compositions and method for the treatment of inflammatory conditions
US4708867A (en) 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4606940A (en) 1984-12-21 1986-08-19 The Ohio State University Research Foundation Small particle formation and encapsulation
DE3536267A1 (de) 1985-10-11 1987-04-16 Bayer Ag Azofarbstoffe sowie fluessigkristallines material enthaltend azofarbstoffe
SE8506015D0 (sv) 1985-12-19 1985-12-19 Draco Ab Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives
GB8630913D0 (en) * 1986-12-24 1987-02-04 Glaxo Group Ltd Pharmaceutical compositions
US4966770A (en) 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
DE10307386A1 (de) 2003-02-21 2004-09-09 Dieter Wildfang Gmbh Verfahren zum außenseitigen Beschichten eines sanitären Auslaufteiles sowie sanitäres Auslaufteil

Also Published As

Publication number Publication date
IL96415A0 (en) 1991-08-16
NO304010B1 (no) 1998-10-12
JP3145111B2 (ja) 2001-03-12
PL166506B1 (pl) 1995-05-31
FI104949B (fi) 2000-05-15
WO1991007172A1 (en) 1991-05-30
YU215090A (sr) 1996-01-09
HRP920632B1 (en) 1999-10-31
LV10183A (lv) 1994-10-20
IE904170A1 (en) 1991-05-22
IS1858B (is) 2003-03-27
FI19991893A (fi) 1999-09-06
IL96415A (en) 1995-11-27
SA90110123B1 (ar) 1999-06-06
IS3644A7 (is) 1991-05-23
RU2134104C1 (ru) 1999-08-10
PL287844A1 (en) 1991-12-02
IE74854B1 (en) 1997-08-13
JPH05501705A (ja) 1993-04-02
AU7786491A (en) 1991-06-13
US6423340B1 (en) 2002-07-23
PT95946A (pt) 1991-09-13
NO922004D0 (no) 1992-05-21
CA2071518C (en) 2002-11-12
KR920703025A (ko) 1992-12-17
HK51897A (en) 1997-05-02
YU48583B (sh) 1998-12-23
MY104535A (en) 1994-04-30
EG19642A (en) 1995-08-30
EP0502092B1 (en) 1995-07-26
LV10183B (en) 1995-08-20
ZA908777B (en) 1991-07-31
DE69021214T2 (de) 1996-01-04
SI9012150A (sl) 1998-08-31
KR0179042B1 (ko) 1999-03-20
DK0502092T3 (da) 1995-12-27
HRP920632A2 (en) 1995-04-30
SG54210A1 (en) 1998-11-16
DE69021214D1 (de) 1995-08-31
LTIP1751A (en) 1995-07-25
EP0502092A1 (en) 1992-09-09
NZ235807A (en) 1993-02-25
FI922325A (fi) 1992-05-21
SE8903914D0 (sv) 1989-11-22
HU9201700D0 (en) 1992-08-28
GR3017691T3 (en) 1996-01-31
LT3696B (en) 1996-02-26
ATE125445T1 (de) 1995-08-15
CA2071518A1 (en) 1991-05-23
HU216836B (hu) 1999-09-28
TW250435B (no) 1995-07-01
ES2074698T3 (es) 1995-09-16
UA37196C2 (uk) 2001-05-15
AU643021B2 (en) 1993-11-04
HUT60630A (en) 1992-10-28
FI922325A0 (fi) 1992-05-21

Similar Documents

Publication Publication Date Title
NO922004D0 (no) Oralt preparat for behandling av inflammatoriske tarmsykdommer
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
ZA899176B (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma and pharmaceutical compositions useful in such treatment
NO883122D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
GB9103764D0 (en) Compositions
NO894222L (no) Fremgangsmaater for behandling og profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer for anvendelse i nevnte metoder.
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO870104D0 (no) Farmasoeytisk preparat med vedvarende frigivelse av den aktive komponenten og fremgangsmaate for fremstilling derav.
NO891723D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO934160L (no) 2-amino-1,2,3,4-tetrahydronaftalen-derivater med kardiovaskulaer aktivitet, fremgangsmaate for fremstilling derav samt farmasoeytiske preparater inneholdende slike
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO960545D0 (no) Behandling av skadelige virkninger i forbindelse med administrering av ekstracellulært hemoglobin
MY114218A (en) The use of bambuterol or a pharmaceutically acceptable salt thereof, to make lipid lowering pharmaceutical preparations.
NO172538C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-fenoksymetyl-4-hydroksytetrahydropyran-2-oner og 6-tiofen-oksymetyl-4-hydroksytetrahydropyran-2-oner
NO890724D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.
NO890519D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater.
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
DK0788355T3 (da) Anvendelse af intravenøst indgiveligt jern til behandling af tumorsygdomme og/eller infektionssygdomme
NO920031D0 (no) Synergistisk middel for terapeutisk behandling, preparat inneholdende nevnte middel, og anvendelse av middelet for fremstilling av et legemiddelpreparat
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
RU95108375A (ru) Способ профилактики и лечения коронарогенных повреждений миокарда
NO880841L (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser.
RU99107944A (ru) Лечебное средство прямого антикоагулянтного и фибринолитического действия

Legal Events

Date Code Title Description
MK1K Patent expired